U.S. flag

An official website of the United States government

NM_001042432.2(CLN3):c.1055dup (p.Cys353fs) AND Neuronal ceroid lipofuscinosis 3

Germline classification:
Likely pathogenic (1 submission)
Last evaluated:
Feb 15, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV003468460.1

Allele description [Variation Report for NM_001042432.2(CLN3):c.1055dup (p.Cys353fs)]

NM_001042432.2(CLN3):c.1055dup (p.Cys353fs)

Gene:
CLN3:CLN3 lysosomal/endosomal transmembrane protein, battenin [Gene - OMIM - HGNC]
Variant type:
Duplication
Cytogenetic location:
16p12.1
Genomic location:
Preferred name:
NM_001042432.2(CLN3):c.1055dup (p.Cys353fs)
HGVS:
  • NC_000016.10:g.28482106dup
  • NG_008654.2:g.15197dup
  • NM_000086.2:c.1055dup
  • NM_001042432.2:c.1055dupMANE SELECT
  • NM_001286104.2:c.983dup
  • NM_001286105.2:c.755dup
  • NM_001286109.2:c.821dup
  • NM_001286110.2:c.893dup
  • NP_000077.1:p.Cys353fs
  • NP_001035897.1:p.Cys353Valfs
  • NP_001035897.1:p.Cys353fs
  • NP_001273033.1:p.Cys329fs
  • NP_001273034.1:p.Cys253fs
  • NP_001273038.1:p.Cys275fs
  • NP_001273039.1:p.Cys299fs
  • LRG_689t1:c.1055dup
  • LRG_689t2:c.1055dup
  • LRG_689:g.15197dup
  • LRG_689p1:p.Cys353fs
  • LRG_689p2:p.Cys353Valfs
  • NC_000016.9:g.28493427dup
  • NM_001042432.1:c.1055dup
Protein change:
C253fs
Molecular consequence:
  • NM_000086.2:c.1055dup - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001042432.2:c.1055dup - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001286104.2:c.983dup - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001286105.2:c.755dup - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001286109.2:c.821dup - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001286110.2:c.893dup - frameshift variant - [Sequence Ontology: SO:0001589]

Condition(s)

Name:
Neuronal ceroid lipofuscinosis 3 (CLN3)
Synonyms:
Spielmeyer Sjogren disease; CLN3 Disease; CLN3-Related Neuronal Ceroid-Lipofuscinosis
Identifiers:
MONDO: MONDO:0008767; MedGen: C0751383; Orphanet: 228346; OMIM: 204200

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Help
Submission AccessionSubmitterReview Status
(Assertion method)		Clinical Significance
(Last evaluated)		OriginMethodCitations
SCV004214346Baylor Genetics
criteria provided, single submitter

(ACMG Guidelines, 2015)		Likely pathogenic
(Feb 15, 2023) 		unknownclinical testing

PubMed (1)
[See all records that cite this PMID]

Help

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedunknownunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee..

Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.

PubMed [citation]
PMID:
25741868
PMCID:
PMC4544753

Details of each submission

From Baylor Genetics, SCV004214346.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Dec 30, 2023